Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24024156 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24024156 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.14226956 |
4 | protein localization to endosome (GO:0036010) | 3.90796785 |
5 | germinal center formation (GO:0002467) | 3.82688357 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81566107 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.77597078 |
8 | response to peptidoglycan (GO:0032494) | 3.71847097 |
9 | negative regulation of interleukin-12 production (GO:0032695) | 3.65939477 |
10 | nuclear pore complex assembly (GO:0051292) | 3.56808969 |
11 | positive regulation of histone deacetylation (GO:0031065) | 3.54364568 |
12 | DNA unwinding involved in DNA replication (GO:0006268) | 3.53753682 |
13 | regulation of translational fidelity (GO:0006450) | 3.51940213 |
14 | macrophage activation involved in immune response (GO:0002281) | 3.49455576 |
15 | mannose metabolic process (GO:0006013) | 3.44594609 |
16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.44088015 |
17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.44088015 |
18 | modulation by symbiont of host immune response (GO:0052553) | 3.44088015 |
19 | positive regulation by symbiont of host defense response (GO:0052509) | 3.44088015 |
20 | modulation by symbiont of host defense response (GO:0052031) | 3.44088015 |
21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.44088015 |
22 | heterochromatin organization (GO:0070828) | 3.42676794 |
23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.41660203 |
24 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.37560542 |
25 | response to muramyl dipeptide (GO:0032495) | 3.36322593 |
26 | positive thymic T cell selection (GO:0045059) | 3.34831507 |
27 | nuclear pore organization (GO:0006999) | 3.34175756 |
28 | NIK/NF-kappaB signaling (GO:0038061) | 3.31415548 |
29 | negative regulation of histone methylation (GO:0031061) | 3.29305352 |
30 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.27608449 |
31 | regulation of gene silencing by miRNA (GO:0060964) | 3.27608449 |
32 | regulation of gene silencing by RNA (GO:0060966) | 3.27608449 |
33 | protein localization to kinetochore (GO:0034501) | 3.27185263 |
34 | pre-miRNA processing (GO:0031054) | 3.25929696 |
35 | COPI coating of Golgi vesicle (GO:0048205) | 3.24534793 |
36 | Golgi transport vesicle coating (GO:0048200) | 3.24534793 |
37 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24428837 |
38 | response to type I interferon (GO:0034340) | 3.17402314 |
39 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16198597 |
40 | tolerance induction (GO:0002507) | 3.15244757 |
41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15091007 |
42 | cellular response to type I interferon (GO:0071357) | 3.14588377 |
43 | type I interferon signaling pathway (GO:0060337) | 3.14588377 |
44 | chromatin assembly (GO:0031497) | 3.13810797 |
45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.12944867 |
46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.12424747 |
47 | DNA duplex unwinding (GO:0032508) | 3.11489432 |
48 | DNA geometric change (GO:0032392) | 3.08135132 |
49 | IMP biosynthetic process (GO:0006188) | 3.03790250 |
50 | maternal placenta development (GO:0001893) | 3.03315846 |
51 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.02769724 |
52 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.02769724 |
53 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.02172512 |
54 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.01333137 |
55 | determination of adult lifespan (GO:0008340) | 2.97367218 |
56 | regulation of histone H3-K9 methylation (GO:0051570) | 2.97278884 |
57 | cellular extravasation (GO:0045123) | 2.96878091 |
58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.95915928 |
59 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95742610 |
60 | dosage compensation (GO:0007549) | 2.95529016 |
61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.94205178 |
62 | positive regulation of protein deacetylation (GO:0090312) | 2.90524929 |
63 | detection of other organism (GO:0098543) | 2.88843657 |
64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85049976 |
65 | pore complex assembly (GO:0046931) | 2.84257681 |
66 | histone H4-K12 acetylation (GO:0043983) | 2.84090613 |
67 | detection of molecule of bacterial origin (GO:0032490) | 2.83772319 |
68 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.82970604 |
69 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.82388675 |
70 | mitotic nuclear envelope disassembly (GO:0007077) | 2.82263425 |
71 | regulation of translational termination (GO:0006449) | 2.82074113 |
72 | RNA stabilization (GO:0043489) | 2.81967170 |
73 | mRNA stabilization (GO:0048255) | 2.81967170 |
74 | leukocyte aggregation (GO:0070486) | 2.80990988 |
75 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.80391218 |
76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80319876 |
77 | negative regulation of T cell mediated immunity (GO:0002710) | 2.79249028 |
78 | mitotic chromosome condensation (GO:0007076) | 2.75549205 |
79 | T cell migration (GO:0072678) | 2.74316717 |
80 | detection of bacterium (GO:0016045) | 2.74305775 |
81 | neutrophil activation involved in immune response (GO:0002283) | 2.73907992 |
82 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.70820441 |
83 | peptidyl-lysine dimethylation (GO:0018027) | 2.70612772 |
84 | membrane disassembly (GO:0030397) | 2.69015010 |
85 | nuclear envelope disassembly (GO:0051081) | 2.69015010 |
86 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.67015964 |
87 | detection of external biotic stimulus (GO:0098581) | 2.66658240 |
88 | thymic T cell selection (GO:0045061) | 2.65489943 |
89 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.65308948 |
90 | immunoglobulin mediated immune response (GO:0016064) | 2.65118879 |
91 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.64398157 |
92 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.64230194 |
93 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.64144723 |
94 | positive regulation of nuclease activity (GO:0032075) | 2.64079899 |
95 | myeloid dendritic cell differentiation (GO:0043011) | 2.63788040 |
96 | trophectodermal cell differentiation (GO:0001829) | 2.63409816 |
97 | response to protozoan (GO:0001562) | 2.62308843 |
98 | protein localization to chromosome, centromeric region (GO:0071459) | 2.61779194 |
99 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.60618304 |
100 | defense response to protozoan (GO:0042832) | 2.60571136 |
101 | regulation of mast cell degranulation (GO:0043304) | 2.59615990 |
102 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.58512504 |
103 | NLS-bearing protein import into nucleus (GO:0006607) | 2.58224324 |
104 | positive regulation of type 2 immune response (GO:0002830) | 2.57517222 |
105 | negative regulation of innate immune response (GO:0045824) | 2.57318097 |
106 | regulation of necroptotic process (GO:0060544) | 2.55603605 |
107 | IMP metabolic process (GO:0046040) | 2.55146306 |
108 | snRNA metabolic process (GO:0016073) | 2.54932639 |
109 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.54719361 |
110 | formation of translation preinitiation complex (GO:0001731) | 2.54295710 |
111 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.53929728 |
112 | regulation of T cell tolerance induction (GO:0002664) | 2.53857825 |
113 | negative regulation of gene silencing (GO:0060969) | 2.53344078 |
114 | regulation of leukocyte degranulation (GO:0043300) | 2.52761504 |
115 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.52138981 |
116 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.52138981 |
117 | regulation of nuclease activity (GO:0032069) | 2.51163694 |
118 | regulation of RNA export from nucleus (GO:0046831) | 2.50905790 |
119 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.50625817 |
120 | histone mRNA catabolic process (GO:0071044) | 2.50193763 |
121 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.49146234 |
122 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.49070260 |
123 | positive regulation of B cell differentiation (GO:0045579) | 2.47310041 |
124 | barbed-end actin filament capping (GO:0051016) | 2.47157002 |
125 | glycosphingolipid catabolic process (GO:0046479) | 2.45185893 |
126 | modulation by symbiont of host cellular process (GO:0044068) | 2.43260920 |
127 | regulation of antigen processing and presentation (GO:0002577) | 2.43018356 |
128 | regulation of type 2 immune response (GO:0002828) | 2.42879163 |
129 | apoptotic process involved in morphogenesis (GO:0060561) | 2.42118099 |
130 | amino sugar catabolic process (GO:0046348) | 2.41929140 |
131 | chromatin silencing (GO:0006342) | 2.41915517 |
132 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.41743224 |
133 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.41713497 |
134 | snRNA processing (GO:0016180) | 2.41527201 |
135 | natural killer cell differentiation (GO:0001779) | 2.40841125 |
136 | nuclear envelope organization (GO:0006998) | 2.40227317 |
137 | B cell receptor signaling pathway (GO:0050853) | 2.40139709 |
138 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.40119973 |
139 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.39908871 |
140 | regulation of gene silencing (GO:0060968) | 2.39401772 |
141 | sister chromatid segregation (GO:0000819) | 2.39231085 |
142 | regulation of interferon-alpha production (GO:0032647) | 2.38912091 |
143 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.37909593 |
144 | response to laminar fluid shear stress (GO:0034616) | 2.37848127 |
145 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37037655 |
146 | positive T cell selection (GO:0043368) | 2.36911634 |
147 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.36800866 |
148 | response to UV-C (GO:0010225) | 2.36258517 |
149 | histone H4-K5 acetylation (GO:0043981) | 2.36217772 |
150 | histone H4-K8 acetylation (GO:0043982) | 2.36217772 |
151 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.36091080 |
152 | myeloid cell activation involved in immune response (GO:0002275) | 2.35935639 |
153 | histone H4-K16 acetylation (GO:0043984) | 2.35414281 |
154 | granulocyte activation (GO:0036230) | 2.35291887 |
155 | interferon-gamma secretion (GO:0072643) | 2.35200867 |
156 | cellular hyperosmotic response (GO:0071474) | 2.34765712 |
157 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.34396716 |
158 | positive regulation of Rap GTPase activity (GO:0032854) | 2.33397539 |
159 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.33281593 |
160 | regulation of vitamin metabolic process (GO:0030656) | 2.33172889 |
161 | T-helper 1 type immune response (GO:0042088) | 2.33172296 |
162 | positive regulation of interferon-alpha production (GO:0032727) | 2.33042647 |
163 | regulation of hippo signaling (GO:0035330) | 2.32722425 |
164 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.32023368 |
165 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.31468593 |
166 | negative regulation of interleukin-6 production (GO:0032715) | 2.31430529 |
167 | cellular response to ethanol (GO:0071361) | 2.31179556 |
168 | positive regulation of antigen processing and presentation (GO:0002579) | 2.30910357 |
169 | DNA conformation change (GO:0071103) | 2.30080075 |
170 | negative regulation of cell killing (GO:0031342) | 2.30036724 |
171 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.30036724 |
172 | negative thymic T cell selection (GO:0045060) | 2.28990584 |
173 | gene silencing (GO:0016458) | 2.28535094 |
174 | mitotic sister chromatid segregation (GO:0000070) | 2.27613647 |
175 | negative T cell selection (GO:0043383) | 2.25965537 |
176 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.25837070 |
177 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.25836812 |
178 | histone H2A monoubiquitination (GO:0035518) | 2.25763930 |
179 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.23715091 |
180 | mRNA cleavage (GO:0006379) | 2.22706227 |
181 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.22486736 |
182 | T cell selection (GO:0045058) | 2.22286192 |
183 | negative regulation of bone resorption (GO:0045779) | 2.20331600 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.14121097 |
2 | MYC_22102868_ChIP-Seq_BL_Human | 3.70340875 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49269882 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.11613931 |
5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67391988 |
6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.63089885 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51796004 |
8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.29558216 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.19445163 |
10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18321421 |
11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98690909 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.97563089 |
13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93426760 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90553560 |
15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.86125786 |
16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85417061 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 1.84586855 |
18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.78380970 |
19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76229520 |
20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.75943658 |
21 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.73978055 |
22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73445249 |
23 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72469020 |
24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.72208347 |
25 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71791990 |
26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71632886 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.71526970 |
28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.70246734 |
29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69353852 |
30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.68061403 |
31 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63249447 |
32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.58237542 |
33 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55073459 |
34 | MYB_26560356_Chip-Seq_TH1_Human | 1.53668872 |
35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53315662 |
36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52131828 |
37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51101718 |
38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49179988 |
39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48492526 |
40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48394183 |
41 | MYB_26560356_Chip-Seq_TH2_Human | 1.47932293 |
42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46733625 |
43 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.46313451 |
44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45976984 |
45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45941439 |
46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.44332646 |
47 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.43628186 |
48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43484496 |
49 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.43404399 |
50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42678640 |
51 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.41739441 |
52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41539748 |
53 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40452171 |
54 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.40224545 |
55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39770936 |
56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38612022 |
57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38528193 |
58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38199641 |
59 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37885996 |
60 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33809640 |
61 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32589461 |
62 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31874765 |
63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31139528 |
64 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30072349 |
65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28647458 |
66 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27980990 |
67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27080574 |
68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26807954 |
69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25128712 |
70 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.24822403 |
71 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.24822403 |
72 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.24822403 |
73 | * MAF_26560356_Chip-Seq_TH2_Human | 1.24647779 |
74 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.24285625 |
75 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24207551 |
76 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.24032444 |
77 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.23934022 |
78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23120208 |
79 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.21953364 |
80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21665478 |
81 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21568728 |
82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21034556 |
83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20572223 |
84 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.20385783 |
85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20113845 |
86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18095210 |
87 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17112358 |
88 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15558026 |
89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15473013 |
90 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14222640 |
91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.13421357 |
92 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13353813 |
93 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13099641 |
94 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12902014 |
95 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12736862 |
96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12398558 |
97 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12390478 |
98 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12371010 |
99 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11829970 |
100 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.11504807 |
101 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11429940 |
102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11081398 |
103 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10868091 |
104 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10605759 |
105 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10381320 |
106 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10067205 |
107 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09321080 |
108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08753644 |
109 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08523491 |
110 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.07851095 |
111 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07310716 |
112 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.07268399 |
113 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07117974 |
114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06827092 |
115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05138448 |
116 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.04516335 |
117 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04341505 |
118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04107198 |
119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03866233 |
120 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03510068 |
121 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02955192 |
122 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02657001 |
123 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02156374 |
124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02146033 |
125 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01994907 |
126 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01943515 |
127 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01938908 |
128 | P68_20966046_ChIP-Seq_HELA_Human | 1.01747400 |
129 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00981375 |
130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00945268 |
131 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00443549 |
132 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.99409387 |
133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99340002 |
134 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98458365 |
135 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97982112 |
136 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97891982 |
137 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97713186 |
138 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97312996 |
139 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96401885 |
140 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95710928 |
141 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95607808 |
142 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95582687 |
143 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95435780 |
144 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95334820 |
145 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94804644 |
146 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94787198 |
147 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.94424179 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003705_abnormal_hypodermis_morpholog | 2.99910375 |
2 | MP0010352_gastrointestinal_tract_polyps | 2.96370695 |
3 | MP0009840_abnormal_foam_cell | 2.94686167 |
4 | MP0005451_abnormal_body_composition | 2.88212272 |
5 | MP0003724_increased_susceptibility_to | 2.64248547 |
6 | MP0002419_abnormal_innate_immunity | 2.32996799 |
7 | MP0004510_myositis | 2.30223482 |
8 | MP0003300_gastrointestinal_ulcer | 2.30081898 |
9 | MP0010307_abnormal_tumor_latency | 2.23735575 |
10 | MP0002148_abnormal_hypersensitivity_rea | 2.23521368 |
11 | MP0002396_abnormal_hematopoietic_system | 2.21596816 |
12 | MP0003763_abnormal_thymus_physiology | 2.20225165 |
13 | MP0003693_abnormal_embryo_hatching | 2.19455946 |
14 | MP0009785_altered_susceptibility_to | 2.16129537 |
15 | MP0005076_abnormal_cell_differentiation | 2.12332920 |
16 | MP0009278_abnormal_bone_marrow | 2.11838383 |
17 | MP0003566_abnormal_cell_adhesion | 2.07388536 |
18 | MP0003111_abnormal_nucleus_morphology | 2.06918902 |
19 | MP0000685_abnormal_immune_system | 1.98940203 |
20 | MP0004957_abnormal_blastocyst_morpholog | 1.98850841 |
21 | MP0003191_abnormal_cellular_cholesterol | 1.98058213 |
22 | MP0002877_abnormal_melanocyte_morpholog | 1.97690970 |
23 | MP0008057_abnormal_DNA_replication | 1.95193100 |
24 | MP0010094_abnormal_chromosome_stability | 1.92615700 |
25 | MP0001533_abnormal_skeleton_physiology | 1.86124293 |
26 | MP0003077_abnormal_cell_cycle | 1.85289260 |
27 | MP0003172_abnormal_lysosome_physiology | 1.84513330 |
28 | MP0004808_abnormal_hematopoietic_stem | 1.82054960 |
29 | MP0002998_abnormal_bone_remodeling | 1.76335391 |
30 | MP0001849_ear_inflammation | 1.74766781 |
31 | MP0001730_embryonic_growth_arrest | 1.72540506 |
32 | MP0002398_abnormal_bone_marrow | 1.64403142 |
33 | MP0001790_abnormal_immune_system | 1.61658987 |
34 | MP0005387_immune_system_phenotype | 1.61658987 |
35 | MP0004947_skin_inflammation | 1.59343271 |
36 | MP0001800_abnormal_humoral_immune | 1.59163216 |
37 | MP0000350_abnormal_cell_proliferation | 1.57919014 |
38 | MP0000703_abnormal_thymus_morphology | 1.56841755 |
39 | MP0005058_abnormal_lysosome_morphology | 1.54792232 |
40 | MP0004264_abnormal_extraembryonic_tissu | 1.51820535 |
41 | MP0003279_aneurysm | 1.50287445 |
42 | MP0000537_abnormal_urethra_morphology | 1.47851128 |
43 | MP0000490_abnormal_crypts_of | 1.47589521 |
44 | MP0000604_amyloidosis | 1.40769141 |
45 | MP0005023_abnormal_wound_healing | 1.39490023 |
46 | MP0000569_abnormal_digit_pigmentation | 1.39198671 |
47 | MP0002405_respiratory_system_inflammati | 1.39030908 |
48 | MP0002722_abnormal_immune_system | 1.38257947 |
49 | MP0003828_pulmonary_edema | 1.37848244 |
50 | MP0003303_peritoneal_inflammation | 1.37562946 |
51 | MP0008260_abnormal_autophagy | 1.37121642 |
52 | MP0002452_abnormal_antigen_presenting | 1.35002118 |
53 | MP0001835_abnormal_antigen_presentation | 1.34801152 |
54 | MP0000689_abnormal_spleen_morphology | 1.34713480 |
55 | MP0004197_abnormal_fetal_growth/weight/ | 1.33949118 |
56 | MP0002420_abnormal_adaptive_immunity | 1.33661925 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.33525847 |
58 | MP0002166_altered_tumor_susceptibility | 1.32923785 |
59 | MP0000343_altered_response_to | 1.31146625 |
60 | MP0008961_abnormal_basal_metabolism | 1.30887078 |
61 | MP0001819_abnormal_immune_cell | 1.30842263 |
62 | MP0004185_abnormal_adipocyte_glucose | 1.29480400 |
63 | MP0010234_abnormal_vibrissa_follicle | 1.29280344 |
64 | MP0000716_abnormal_immune_system | 1.28532578 |
65 | MP0005310_abnormal_salivary_gland | 1.27712180 |
66 | MP0008469_abnormal_protein_level | 1.26199582 |
67 | MP0001672_abnormal_embryogenesis/_devel | 1.23199841 |
68 | MP0005380_embryogenesis_phenotype | 1.23199841 |
69 | MP0009764_decreased_sensitivity_to | 1.23126082 |
70 | MP0002086_abnormal_extraembryonic_tissu | 1.23099770 |
71 | MP0000733_abnormal_muscle_development | 1.23013397 |
72 | MP0008007_abnormal_cellular_replicative | 1.21454896 |
73 | MP0003984_embryonic_growth_retardation | 1.21219352 |
74 | MP0002088_abnormal_embryonic_growth/wei | 1.20649609 |
75 | MP0002723_abnormal_immune_serum | 1.20563341 |
76 | MP0002429_abnormal_blood_cell | 1.19929361 |
77 | MP0002019_abnormal_tumor_incidence | 1.19613891 |
78 | MP0001545_abnormal_hematopoietic_system | 1.18913954 |
79 | MP0005397_hematopoietic_system_phenotyp | 1.18913954 |
80 | MP0000465_gastrointestinal_hemorrhage | 1.18390336 |
81 | MP0003436_decreased_susceptibility_to | 1.17351856 |
82 | MP0010155_abnormal_intestine_physiology | 1.16724883 |
83 | MP0003283_abnormal_digestive_organ | 1.16651810 |
84 | MP0005000_abnormal_immune_tolerance | 1.15595963 |
85 | MP0000015_abnormal_ear_pigmentation | 1.14723749 |
86 | MP0001853_heart_inflammation | 1.14187123 |
87 | MP0002084_abnormal_developmental_patter | 1.12306282 |
88 | MP0002080_prenatal_lethality | 1.11261015 |
89 | MP0008058_abnormal_DNA_repair | 1.11059689 |
90 | MP0001958_emphysema | 1.10258774 |
91 | MP0001697_abnormal_embryo_size | 1.09806410 |
92 | MP0003075_altered_response_to | 1.09438351 |
93 | MP0004381_abnormal_hair_follicle | 1.09069113 |
94 | MP0000313_abnormal_cell_death | 1.08750479 |
95 | MP0000858_altered_metastatic_potential | 1.08160750 |
96 | MP0001873_stomach_inflammation | 1.06824287 |
97 | MP0002085_abnormal_embryonic_tissue | 1.06036238 |
98 | MP0001851_eye_inflammation | 1.04121008 |
99 | MP0006082_CNS_inflammation | 1.03488215 |
100 | MP0004233_abnormal_muscle_weight | 1.02986059 |
101 | MP0003091_abnormal_cell_migration | 1.02575181 |
102 | MP0002332_abnormal_exercise_endurance | 1.00754348 |
103 | MP0008004_abnormal_stomach_pH | 0.96680421 |
104 | MP0005671_abnormal_response_to | 0.96458697 |
105 | MP0009672_abnormal_birth_weight | 0.95808810 |
106 | MP0000371_diluted_coat_color | 0.94756188 |
107 | MP0000767_abnormal_smooth_muscle | 0.94492854 |
108 | MP0003866_abnormal_defecation | 0.94412794 |
109 | MP0004130_abnormal_muscle_cell | 0.94038503 |
110 | MP0000003_abnormal_adipose_tissue | 0.93730324 |
111 | MP0005164_abnormal_response_to | 0.93296333 |
112 | MP0003448_altered_tumor_morphology | 0.92838009 |
113 | MP0005464_abnormal_platelet_physiology | 0.92702117 |
114 | MP0002933_joint_inflammation | 0.90924268 |
115 | MP0003453_abnormal_keratinocyte_physiol | 0.90413073 |
116 | MP0006054_spinal_hemorrhage | 0.90156843 |
117 | MP0005621_abnormal_cell_physiology | 0.89928462 |
118 | MP0000428_abnormal_craniofacial_morphol | 0.89387961 |
119 | MP0000477_abnormal_intestine_morphology | 0.87492157 |
120 | MP0005390_skeleton_phenotype | 0.86288006 |
121 | MP0003329_amyloid_beta_deposits | 0.84727441 |
122 | MP0004858_abnormal_nervous_system | 0.84470194 |
123 | MP0003795_abnormal_bone_structure | 0.83521221 |
124 | MP0008438_abnormal_cutaneous_collagen | 0.82537315 |
125 | MP0009703_decreased_birth_body | 0.82249012 |
126 | MP0005025_abnormal_response_to | 0.81781872 |
127 | MP0001348_abnormal_lacrimal_gland | 0.81500370 |
128 | MP0003045_fibrosis | 0.80525565 |
129 | MP0002006_tumorigenesis | 0.80259411 |
130 | MP0003656_abnormal_erythrocyte_physiolo | 0.79766467 |
131 | MP0002925_abnormal_cardiovascular_devel | 0.78252293 |
132 | MP0001845_abnormal_inflammatory_respons | 0.77293996 |
133 | MP0008770_decreased_survivor_rate | 0.76402612 |
134 | MP0001915_intracranial_hemorrhage | 0.75922227 |
135 | MP0001663_abnormal_digestive_system | 0.75584898 |
136 | MP0005166_decreased_susceptibility_to | 0.75302517 |
137 | MP0001216_abnormal_epidermal_layer | 0.75221410 |
138 | MP0000249_abnormal_blood_vessel | 0.75008825 |
139 | MP0002139_abnormal_hepatobiliary_system | 0.73919755 |
140 | MP0003690_abnormal_glial_cell | 0.73626783 |
141 | MP0005257_abnormal_intraocular_pressure | 0.73365480 |
142 | MP0003890_abnormal_embryonic-extraembry | 0.72556927 |
143 | MP0005384_cellular_phenotype | 0.72534693 |
144 | MP0004883_abnormal_blood_vessel | 0.71966884 |
145 | MP0003183_abnormal_peptide_metabolism | 0.69186841 |
146 | MP0005409_darkened_coat_color | 0.66870641 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.75227243 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.75227243 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.75227243 |
4 | Abnormality of macrophages (HP:0004311) | 3.67409946 |
5 | Recurrent abscess formation (HP:0002722) | 3.56458368 |
6 | Increased cerebral lipofuscin (HP:0011813) | 3.49485198 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.43960824 |
8 | Loss of speech (HP:0002371) | 3.42604279 |
9 | Ependymoma (HP:0002888) | 3.41263624 |
10 | Myositis (HP:0100614) | 3.13717365 |
11 | Cerebral aneurysm (HP:0004944) | 3.11740860 |
12 | Abnormality of the fingertips (HP:0001211) | 3.05132900 |
13 | Orchitis (HP:0100796) | 3.04715798 |
14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.96395066 |
15 | Ulnar bowing (HP:0003031) | 2.91468391 |
16 | Nasal polyposis (HP:0100582) | 2.76870315 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 2.76294568 |
18 | T lymphocytopenia (HP:0005403) | 2.73341235 |
19 | Systemic lupus erythematosus (HP:0002725) | 2.72331047 |
20 | Retrobulbar optic neuritis (HP:0100654) | 2.72189371 |
21 | Optic neuritis (HP:0100653) | 2.72189371 |
22 | Hand muscle atrophy (HP:0009130) | 2.60723138 |
23 | Basal cell carcinoma (HP:0002671) | 2.58849573 |
24 | Recurrent bronchitis (HP:0002837) | 2.56969639 |
25 | Vacuolated lymphocytes (HP:0001922) | 2.51053082 |
26 | Distal upper limb amyotrophy (HP:0007149) | 2.48305812 |
27 | Upper limb amyotrophy (HP:0009129) | 2.48305812 |
28 | Recurrent viral infections (HP:0004429) | 2.45102826 |
29 | Hyperacusis (HP:0010780) | 2.43922729 |
30 | Abnormality of T cell number (HP:0011839) | 2.43411905 |
31 | Vertebral compression fractures (HP:0002953) | 2.42815568 |
32 | Stomatitis (HP:0010280) | 2.42434303 |
33 | Selective tooth agenesis (HP:0001592) | 2.41452494 |
34 | Nuclear cataract (HP:0100018) | 2.37916933 |
35 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.37782393 |
36 | Heterotopia (HP:0002282) | 2.36326308 |
37 | Gastrointestinal stroma tumor (HP:0100723) | 2.36064682 |
38 | Spontaneous hematomas (HP:0007420) | 2.35295307 |
39 | Pustule (HP:0200039) | 2.34853383 |
40 | Recurrent skin infections (HP:0001581) | 2.31238561 |
41 | Gingivitis (HP:0000230) | 2.30547948 |
42 | Metaphyseal cupping (HP:0003021) | 2.29919353 |
43 | Abnormality of the nasal mucosa (HP:0000433) | 2.29554017 |
44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27410933 |
45 | Abnormality of the astrocytes (HP:0100707) | 2.25725489 |
46 | Astrocytoma (HP:0009592) | 2.25725489 |
47 | Cellulitis (HP:0100658) | 2.25504366 |
48 | Cervical subluxation (HP:0003308) | 2.22928787 |
49 | Prominent nose (HP:0000448) | 2.17940616 |
50 | Myocardial infarction (HP:0001658) | 2.17279220 |
51 | Missing ribs (HP:0000921) | 2.16863964 |
52 | IgM deficiency (HP:0002850) | 2.16643783 |
53 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16525276 |
54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16525276 |
55 | Asymmetric septal hypertrophy (HP:0001670) | 2.16455264 |
56 | High pitched voice (HP:0001620) | 2.14256605 |
57 | Gastrointestinal inflammation (HP:0004386) | 2.12427853 |
58 | Slow saccadic eye movements (HP:0000514) | 2.12262406 |
59 | Vasculitis (HP:0002633) | 2.10226792 |
60 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09341211 |
61 | Biliary tract neoplasm (HP:0100574) | 2.09283416 |
62 | Pulmonary infiltrates (HP:0002113) | 2.09039512 |
63 | Abnormality of T cells (HP:0002843) | 2.09007218 |
64 | Ulnar deviation of the wrist (HP:0003049) | 2.08765175 |
65 | Agnosia (HP:0010524) | 2.08137624 |
66 | Malnutrition (HP:0004395) | 2.08058440 |
67 | 11 pairs of ribs (HP:0000878) | 2.07494510 |
68 | Increased density of long bones (HP:0006392) | 2.07479223 |
69 | Neuronal loss in central nervous system (HP:0002529) | 2.06865851 |
70 | Thrombocytosis (HP:0001894) | 2.06629757 |
71 | Neurofibrillary tangles (HP:0002185) | 2.06261289 |
72 | Inflammation of the large intestine (HP:0002037) | 2.03744377 |
73 | Persistence of primary teeth (HP:0006335) | 2.00629441 |
74 | Obstructive lung disease (HP:0006536) | 1.98953880 |
75 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98953880 |
76 | Distal lower limb amyotrophy (HP:0008944) | 1.97919871 |
77 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.96912163 |
78 | Macroorchidism (HP:0000053) | 1.96419310 |
79 | Meningitis (HP:0001287) | 1.94563675 |
80 | Gastrointestinal carcinoma (HP:0002672) | 1.93766276 |
81 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.93766276 |
82 | Broad face (HP:0000283) | 1.92328110 |
83 | Broad palm (HP:0001169) | 1.91268310 |
84 | Hemoptysis (HP:0002105) | 1.91013678 |
85 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.89100304 |
86 | Spinal muscular atrophy (HP:0007269) | 1.88917494 |
87 | Purpura (HP:0000979) | 1.88541114 |
88 | Mitral valve prolapse (HP:0001634) | 1.88378306 |
89 | Chronic otitis media (HP:0000389) | 1.88219602 |
90 | Glomerulonephritis (HP:0000099) | 1.87957505 |
91 | Recurrent fungal infections (HP:0002841) | 1.87736843 |
92 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.87000682 |
93 | Overlapping toe (HP:0001845) | 1.86691182 |
94 | Axonal loss (HP:0003447) | 1.86666042 |
95 | Interstitial pulmonary disease (HP:0006530) | 1.86162012 |
96 | Eczematoid dermatitis (HP:0000976) | 1.86027228 |
97 | Abnormality of the calcaneus (HP:0008364) | 1.84897626 |
98 | Keratoconjunctivitis sicca (HP:0001097) | 1.84290607 |
99 | Medulloblastoma (HP:0002885) | 1.84197321 |
100 | Increased serum ferritin (HP:0003281) | 1.84070454 |
101 | Restrictive lung disease (HP:0002091) | 1.83466377 |
102 | Thin bony cortex (HP:0002753) | 1.83374080 |
103 | Spondylolisthesis (HP:0003302) | 1.82633566 |
104 | Severe short stature (HP:0003510) | 1.82355190 |
105 | Abnormality of T cell physiology (HP:0011840) | 1.80887076 |
106 | Achilles tendon contracture (HP:0001771) | 1.80824638 |
107 | IgA deficiency (HP:0002720) | 1.80743261 |
108 | Cerebral inclusion bodies (HP:0100314) | 1.80229585 |
109 | Colon cancer (HP:0003003) | 1.80007424 |
110 | Flat acetabular roof (HP:0003180) | 1.78943100 |
111 | Hematochezia (HP:0002573) | 1.78705100 |
112 | Gastrointestinal infarctions (HP:0005244) | 1.78465059 |
113 | Autoimmune thrombocytopenia (HP:0001973) | 1.78114160 |
114 | Verrucae (HP:0200043) | 1.77667734 |
115 | Papilloma (HP:0012740) | 1.77667734 |
116 | Emphysema (HP:0002097) | 1.76522563 |
117 | Bone pain (HP:0002653) | 1.76394812 |
118 | Colitis (HP:0002583) | 1.76368613 |
119 | Disinhibition (HP:0000734) | 1.75248773 |
120 | Vertebral clefting (HP:0008428) | 1.74897345 |
121 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.73355901 |
122 | Mucopolysacchariduria (HP:0008155) | 1.73355901 |
123 | Cutaneous melanoma (HP:0012056) | 1.72610629 |
124 | Upper motor neuron abnormality (HP:0002127) | 1.72591186 |
125 | Bicuspid aortic valve (HP:0001647) | 1.72518363 |
126 | Thoracic kyphosis (HP:0002942) | 1.72397010 |
127 | Radial bowing (HP:0002986) | 1.72314979 |
128 | Mitral regurgitation (HP:0001653) | 1.71947887 |
129 | Bowing of the arm (HP:0006488) | 1.71334377 |
130 | Bowed forearm bones (HP:0003956) | 1.71334377 |
131 | Amyloidosis (HP:0011034) | 1.71330744 |
132 | Global brain atrophy (HP:0002283) | 1.71064617 |
133 | Protrusio acetabuli (HP:0003179) | 1.70971401 |
134 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.70736704 |
135 | Amaurosis fugax (HP:0100576) | 1.70726888 |
136 | Skin tags (HP:0010609) | 1.69684173 |
137 | Neoplasm of the oral cavity (HP:0100649) | 1.68391016 |
138 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68049658 |
139 | Genu recurvatum (HP:0002816) | 1.68041079 |
140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.67465993 |
141 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.67465993 |
142 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.67465993 |
143 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.67251717 |
144 | Increased IgE level (HP:0003212) | 1.67145162 |
145 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.67039537 |
146 | Cafe-au-lait spot (HP:0000957) | 1.66597226 |
147 | Broad thumb (HP:0011304) | 1.66324641 |
148 | Dilatation of the ascending aorta (HP:0005111) | 1.66272616 |
149 | Supranuclear gaze palsy (HP:0000605) | 1.66205976 |
150 | Abnormality of the endocardium (HP:0004306) | 1.65799951 |
151 | Aortic aneurysm (HP:0004942) | 1.64072882 |
152 | Joint stiffness (HP:0001387) | 1.63309274 |
153 | Sandal gap (HP:0001852) | 1.62554746 |
154 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.62503849 |
155 | Vertebral hypoplasia (HP:0008417) | 1.62503849 |
156 | Myopathic facies (HP:0002058) | 1.62285174 |
157 | Difficulty climbing stairs (HP:0003551) | 1.61724932 |
158 | Neoplasm of striated muscle (HP:0009728) | 1.61440911 |
159 | Angiofibromas (HP:0010615) | 1.61437518 |
160 | Adenoma sebaceum (HP:0009720) | 1.61437518 |
161 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.61104928 |
162 | Frequent falls (HP:0002359) | 1.59464069 |
163 | Deviation of the thumb (HP:0009603) | 1.58901247 |
164 | Lymphopenia (HP:0001888) | 1.58845376 |
165 | Increased connective tissue (HP:0009025) | 1.57776382 |
166 | Aneurysm (HP:0002617) | 1.57686965 |
167 | Myelodysplasia (HP:0002863) | 1.56982049 |
168 | Dysostosis multiplex (HP:0000943) | 1.55425613 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 3.89210683 |
2 | EEF2K | 3.65928375 |
3 | TRIB3 | 3.32994351 |
4 | PKN2 | 3.26976369 |
5 | PRPF4B | 3.18418076 |
6 | MAP4K1 | 3.03397451 |
7 | MAP3K10 | 2.98874200 |
8 | RIPK4 | 2.73806161 |
9 | ERN1 | 2.59634211 |
10 | STK10 | 2.44802699 |
11 | MAP3K13 | 2.29740884 |
12 | BLK | 2.24872558 |
13 | NEK2 | 1.92682978 |
14 | TTN | 1.83908820 |
15 | ICK | 1.82453658 |
16 | GRK6 | 1.75390496 |
17 | JAK3 | 1.71986607 |
18 | PASK | 1.67700167 |
19 | IRAK4 | 1.67467851 |
20 | LRRK2 | 1.64885627 |
21 | RPS6KB2 | 1.59051417 |
22 | TAOK2 | 1.58221209 |
23 | CDC42BPA | 1.52831555 |
24 | FLT3 | 1.45326087 |
25 | EPHB1 | 1.44120707 |
26 | PTK6 | 1.43773682 |
27 | CDC7 | 1.43610297 |
28 | MAP3K11 | 1.41362634 |
29 | SMG1 | 1.39223886 |
30 | ALK | 1.32298181 |
31 | ZAP70 | 1.29926700 |
32 | SCYL2 | 1.28948962 |
33 | IKBKE | 1.26733597 |
34 | TAOK1 | 1.24990101 |
35 | MAP3K8 | 1.24734166 |
36 | CAMK1G | 1.22942659 |
37 | RPS6KA4 | 1.20063566 |
38 | MTOR | 1.19368833 |
39 | MAP3K1 | 1.12063289 |
40 | BRD4 | 1.11043892 |
41 | CSF1R | 1.06678688 |
42 | CAMKK1 | 1.06495273 |
43 | CDK4 | 1.06469883 |
44 | FGFR4 | 1.06289020 |
45 | ITK | 1.04873661 |
46 | HIPK2 | 1.02182791 |
47 | TXK | 1.01223400 |
48 | MATK | 0.98389863 |
49 | BTK | 0.95658925 |
50 | FES | 0.94355644 |
51 | TGFBR2 | 0.94045444 |
52 | PAK4 | 0.93860578 |
53 | DDR2 | 0.93816713 |
54 | CAMK1D | 0.93457887 |
55 | CDK7 | 0.93380643 |
56 | TTK | 0.93195766 |
57 | PDGFRA | 0.92884466 |
58 | PIM1 | 0.92515356 |
59 | MAPK7 | 0.92394396 |
60 | IRAK3 | 0.91549331 |
61 | EPHA2 | 0.89653299 |
62 | FGR | 0.89248281 |
63 | SIK1 | 0.88778853 |
64 | MAPK12 | 0.87991390 |
65 | TYK2 | 0.87376358 |
66 | ATR | 0.85926492 |
67 | NEK9 | 0.85905117 |
68 | PDPK1 | 0.85325726 |
69 | MAP2K2 | 0.84168260 |
70 | MAPKAPK3 | 0.83120345 |
71 | FGFR3 | 0.82764318 |
72 | MOS | 0.82265827 |
73 | RPS6KA2 | 0.82232727 |
74 | CSK | 0.82127147 |
75 | STK4 | 0.81498651 |
76 | CHUK | 0.80238510 |
77 | CDK6 | 0.78661641 |
78 | HCK | 0.78366810 |
79 | TBK1 | 0.77382293 |
80 | MAPK11 | 0.77048775 |
81 | NME2 | 0.76111653 |
82 | CHEK1 | 0.74424606 |
83 | LCK | 0.73163487 |
84 | BMX | 0.72294855 |
85 | RPS6KL1 | 0.71361024 |
86 | RPS6KC1 | 0.71361024 |
87 | MAP3K6 | 0.71135920 |
88 | PAK2 | 0.70618025 |
89 | GRK7 | 0.70398939 |
90 | MAP2K3 | 0.70095265 |
91 | TGFBR1 | 0.68587867 |
92 | PDK1 | 0.67724955 |
93 | TESK2 | 0.66773819 |
94 | IRAK2 | 0.65974047 |
95 | PDGFRB | 0.65906308 |
96 | JAK1 | 0.65853724 |
97 | CAMKK2 | 0.65637593 |
98 | JAK2 | 0.62749033 |
99 | KIT | 0.61891616 |
100 | LYN | 0.61758314 |
101 | WNK1 | 0.61292031 |
102 | IKBKB | 0.61291469 |
103 | PIM2 | 0.61165347 |
104 | MAP3K2 | 0.61006651 |
105 | CLK1 | 0.60921500 |
106 | TRPM7 | 0.60025542 |
107 | RPS6KA6 | 0.59173638 |
108 | SYK | 0.58767920 |
109 | SGK3 | 0.57927280 |
110 | CDK2 | 0.56960079 |
111 | RET | 0.55711559 |
112 | SIK2 | 0.55195900 |
113 | MAP3K7 | 0.54803852 |
114 | MAP2K6 | 0.54715533 |
115 | STK38 | 0.54646655 |
116 | MARK3 | 0.54423508 |
117 | TNK2 | 0.54420331 |
118 | TYRO3 | 0.54136530 |
119 | MST4 | 0.53979304 |
120 | KSR2 | 0.53091470 |
121 | ATM | 0.52862813 |
122 | PTK2 | 0.50497451 |
123 | PRKCH | 0.48828162 |
124 | RIPK1 | 0.48135518 |
125 | WNK4 | 0.47963572 |
126 | STK3 | 0.47425456 |
127 | PRKD3 | 0.47406730 |
128 | AURKB | 0.46859954 |
129 | SIK3 | 0.46094013 |
130 | MELK | 0.45737043 |
131 | MST1R | 0.45161007 |
132 | TAOK3 | 0.44300583 |
133 | PRKD2 | 0.43685212 |
134 | MAP3K3 | 0.43186057 |
135 | PRKCI | 0.41546308 |
136 | MAPKAPK2 | 0.41425545 |
137 | PNCK | 0.41263876 |
138 | MARK2 | 0.40933266 |
139 | MAP3K14 | 0.40226408 |
140 | MAPK1 | 0.40210977 |
141 | DYRK1B | 0.40209596 |
142 | DYRK3 | 0.39011286 |
Rank | Gene Set | Z-score |
---|---|---|
1 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.00655137 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.98861729 |
3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97713531 |
4 | DNA replication_Homo sapiens_hsa03030 | 1.94852866 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92317553 |
6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.90459559 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 1.85388419 |
8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.85306420 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81957592 |
10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.68517716 |
11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.60207519 |
12 | Base excision repair_Homo sapiens_hsa03410 | 1.58026254 |
13 | RNA transport_Homo sapiens_hsa03013 | 1.51288926 |
14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.50903478 |
15 | Allograft rejection_Homo sapiens_hsa05330 | 1.49980461 |
16 | Malaria_Homo sapiens_hsa05144 | 1.46131342 |
17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45426816 |
18 | Spliceosome_Homo sapiens_hsa03040 | 1.41056079 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40157390 |
20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39780815 |
21 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.39045282 |
22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35531415 |
23 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.34649904 |
24 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.32860981 |
25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.32449997 |
26 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.31196769 |
27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30849800 |
28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.30685286 |
29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30019070 |
30 | Pertussis_Homo sapiens_hsa05133 | 1.29480051 |
31 | HTLV-I infection_Homo sapiens_hsa05166 | 1.27222201 |
32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27154031 |
33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25758202 |
34 | Apoptosis_Homo sapiens_hsa04210 | 1.25232680 |
35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.21346986 |
36 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21099110 |
37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.20932812 |
38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18226231 |
39 | Measles_Homo sapiens_hsa05162 | 1.17470858 |
40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17010075 |
41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16738302 |
42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16400787 |
43 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.15029273 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14786519 |
45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14496924 |
46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13850512 |
47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13360465 |
48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13350016 |
49 | Colorectal cancer_Homo sapiens_hsa05210 | 1.12988516 |
50 | Cell cycle_Homo sapiens_hsa04110 | 1.12571279 |
51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10128196 |
52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09885039 |
53 | Shigellosis_Homo sapiens_hsa05131 | 1.08459391 |
54 | Lysine degradation_Homo sapiens_hsa00310 | 1.06171634 |
55 | Thyroid cancer_Homo sapiens_hsa05216 | 1.05271595 |
56 | Phagosome_Homo sapiens_hsa04145 | 1.02153932 |
57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00915778 |
58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99077527 |
59 | Hepatitis B_Homo sapiens_hsa05161 | 0.99049651 |
60 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97524481 |
61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97335541 |
62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96080678 |
63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96043008 |
64 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94926212 |
65 | Insulin resistance_Homo sapiens_hsa04931 | 0.93531537 |
66 | Prion diseases_Homo sapiens_hsa05020 | 0.93445706 |
67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93362251 |
68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92489987 |
69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91323083 |
70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.91319375 |
71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90580435 |
72 | Influenza A_Homo sapiens_hsa05164 | 0.90476513 |
73 | Legionellosis_Homo sapiens_hsa05134 | 0.90097617 |
74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89613700 |
75 | Lysosome_Homo sapiens_hsa04142 | 0.88695324 |
76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88331210 |
77 | Adherens junction_Homo sapiens_hsa04520 | 0.87252300 |
78 | Bladder cancer_Homo sapiens_hsa05219 | 0.87149023 |
79 | Amoebiasis_Homo sapiens_hsa05146 | 0.86786034 |
80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85912513 |
81 | Asthma_Homo sapiens_hsa05310 | 0.85731896 |
82 | Focal adhesion_Homo sapiens_hsa04510 | 0.85373990 |
83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84550193 |
84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83573280 |
85 | RNA degradation_Homo sapiens_hsa03018 | 0.82122379 |
86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81957283 |
87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81588136 |
88 | Prostate cancer_Homo sapiens_hsa05215 | 0.81054694 |
89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81014162 |
90 | Platelet activation_Homo sapiens_hsa04611 | 0.79946641 |
91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78460094 |
92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77866029 |
93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76379907 |
94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75240366 |
95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.74359931 |
96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74210111 |
97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73845405 |
98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73614281 |
99 | Homologous recombination_Homo sapiens_hsa03440 | 0.72885990 |
100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72635656 |
101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71192117 |
102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70912899 |
103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70766912 |
104 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69659677 |
105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69484438 |
106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69025784 |
107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68337590 |
108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.68326630 |
109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68029576 |
110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67889362 |
111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67400372 |
112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67367747 |
113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.67155884 |
114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66952212 |
115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66166931 |
116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65478004 |
117 | Tuberculosis_Homo sapiens_hsa05152 | 0.63593892 |
118 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63548689 |
119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62166320 |
120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61387095 |
121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61020851 |
122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60961121 |
123 | Hepatitis C_Homo sapiens_hsa05160 | 0.60217318 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59587109 |
125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58738041 |
126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58020052 |
127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57779840 |
128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56792843 |
129 | Endocytosis_Homo sapiens_hsa04144 | 0.56128841 |
130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55495032 |
131 | Salmonella infection_Homo sapiens_hsa05132 | 0.55448670 |
132 | Glioma_Homo sapiens_hsa05214 | 0.54864081 |
133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49664084 |
134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46887316 |